FLT3 Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesFLK2; STK1; CD135; FLK-2
ProductOrderF
Clone#7B7C3
Entrez GenelD2322
FormulationPurified antibody in PBS with 0.05% sodium azide
HostMouse
IsotypeIgG1
ImmunogenPurified recombinant fragment of human FLT3 (AA: 930-991) expressed in E. Coli.
MW130kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
IHC_P(Immunohistochemistry)1/200 - 1/1000
WB (Western Blot)1/500 - 1/2000
Sequence
930-991
Catalog#: 30507
Inquire
Contact us to order
Images
Western Blot
Figure 1: Western blot analysis using FLT3 mAb against human FLT3 recombinant protein. (Expected MW is 32.6 kDa)
Figure 1: Western blot analysis using FLT3 mAb against human FLT3 recombinant protein. (Expected MW is 32.6 kDa)
Immunohistochemical analysis
Figure 2: Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using FLT3 mouse mAb with DAB staining.
Figure 2: Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using FLT3 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 3: Immunohistochemical analysis of paraffin-embedded liver cancer tissues using FLT3 mouse mAb with DAB staining.
Figure 3: Immunohistochemical analysis of paraffin-embedded liver cancer tissues using FLT3 mouse mAb with DAB staining.
Elisa
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Product Overview
DescriptionThis gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.
References (references)
References (references)1. J Immunol. 2012 Oct 15;189(8):3822-30.
2. Cancer. 2012 Dec 15;118(24):6110-7.